MAL transcripts were found significantly overexpressed in ovarian cancer cell lines resistant to traditional platinum-based and other chemotherapeutics compared with sensitive ones [130,178] and in the tumor cells of platinum-resistant compared to platinum-sensitive patients that received platinum-based chemotherapy [178]. This evidence concerns the gene MAL and ovarian cancer.